Cytokinetics, Incorporated

BIT:1CYTK Stock Report

Market Cap: €3.4b

Cytokinetics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BIT:1CYTK Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 May 25Sell€129,574Andrew CallosIndividual4,002€32.38
29 Apr 25Sell€179,651Robert BlumIndividual5,000€35.93
10 Apr 25Sell€164,380Robert BlumIndividual5,000€32.88
07 Apr 25Sell€94,515Andrew CallosIndividual2,886€32.75
03 Apr 25Sell€16,029Robert HarringtonIndividual450€35.62
31 Mar 25Sell€565,529Robert BlumIndividual15,000€37.70
17 Mar 25Sell€112,785Andrew CallosIndividual2,775€40.64
17 Mar 25Sell€1,536,317Robert BlumIndividual37,648€40.89
17 Mar 25Sell€178,383Fady MalikIndividual4,389€40.64
13 Mar 25Sell€1,074,915Andrew CallosIndividual26,771€40.15
06 Mar 25Sell€328,754Fady MalikIndividual8,228€39.96
06 Mar 25Sell€680,709Robert BlumIndividual16,970€40.11
06 Mar 25Sell€133,491Andrew CallosIndividual3,341€39.96
05 Mar 25Sell€1,350,989Robert BlumIndividual33,743€40.12
04 Mar 25Sell€36,322Robert HarringtonIndividual900€40.36
03 Mar 25Sell€100,046Fady MalikIndividual2,449€40.85
03 Mar 25Sell€45,509Andrew CallosIndividual1,114€40.85
10 Dec 24Sell€96,417Fady MalikIndividual2,000€48.21
26 Nov 24Sell€95,767Fady MalikIndividual2,000€47.88
12 Nov 24Sell€57,432Fady MalikIndividual1,042€55.12
30 Oct 24Sell€95,634Fady MalikIndividual2,000€47.82
15 Oct 24Sell€99,403Fady MalikIndividual2,000€49.70
01 Oct 24Sell€94,152Fady MalikIndividual2,000€47.08
17 Sep 24Sell€102,111Fady MalikIndividual2,000€51.06
03 Sep 24Sell€107,636Fady MalikIndividual2,084€51.65
20 Aug 24Sell€101,293Fady MalikIndividual2,000€50.65
06 Aug 24Sell€98,239Fady MalikIndividual2,000€49.12
23 Jul 24Sell€105,054Fady MalikIndividual2,000€52.53
10 Jul 24Sell€287,528Robert BlumIndividual5,733€50.15
09 Jul 24Sell€103,408Fady MalikIndividual2,000€51.70
05 Jul 24Sell€12,762Robert HarringtonIndividual253€50.44
01 Jul 24Sell€579,681Robert BlumIndividual11,500€50.41
25 Jun 24Sell€100,419Fady MalikIndividual2,000€50.21
17 Jun 24Sell€1,103,630Robert BlumIndividual22,500€49.05
11 Jun 24Sell€116,975Fady MalikIndividual2,366€49.44
10 Jun 24Sell€96,934Muna BhanjiIndividual2,000€48.47
03 Jun 24Sell€584,209Robert WongIndividual13,011€44.90
03 Jun 24Sell€70,596Robert HarringtonIndividual1,580€44.68

Insider Trading Volume

Insider Buying: 1CYTK insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1CYTK?
Owner TypeNumber of SharesOwnership Percentage
State or Government44,8660.0334%
Private Companies105,8840.0787%
Individual Insiders519,9930.387%
Institutions133,799,29299.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 82.3% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13%
BlackRock, Inc.
15,563,634€444.7m0.61%0.01%
11.2%
T. Rowe Price Group, Inc.
13,420,144€383.5m0.32%0.04%
9.92%
The Vanguard Group, Inc.
11,849,547€338.6m-0.56%0.01%
9.04%
FMR LLC
10,794,227€308.5m-10.8%0.02%
6.61%
Wellington Management Group LLP
7,888,697€225.4m1.46%0.04%
5.16%
State Street Global Advisors, Inc.
6,167,340€176.2m-4.51%0.01%
2.38%
Geode Capital Management, LLC
2,841,338€81.2m-0.25%0.01%
2.28%
RTW Investments, LP
2,721,158€77.8m0%1.37%
2.09%
Deep Track Capital, LP
2,500,000€71.4m297%3.36%
1.97%
Vestal Point Capital, LP
2,350,000€67.2m56.7%5.23%
1.84%
Polar Capital Holdings Plc
2,196,721€62.8m-6.04%0.25%
1.8%
Marshall Wace LLP
2,153,313€61.5m14.9%0.1%
1.64%
Pictet Asset Management Limited
1,956,327€55.9m2.32%0.04%
1.34%
AllianceBernstein L.P.
1,595,324€45.6m-3.95%0.02%
1.33%
OrbiMed Advisors LLC
1,584,005€45.3m107%0.81%
1.27%
UBS Asset Management AG
1,517,249€43.4m161%no data
1.23%
Northern Trust Global Investments
1,471,489€42.0m10.7%0.01%
1.15%
Citadel Advisors LLC
1,371,645€39.2m46.4%0.04%
1.1%
Charles Schwab Investment Management, Inc.
1,312,857€37.5m-1.67%0.01%
1.1%
Armistice Capital LLC
1,312,000€37.5m-30.8%1.09%
1.1%
Westfield Capital Management Company, L.P.
1,310,336€37.4m2.37%0.19%
0.95%
Melqart Asset Management (Uk) Ltd
1,136,434€32.5m-6.25%5.35%
0.92%
Capital Research and Management Company
1,096,164€31.3m872%no data
0.91%
Pentwater Capital Management LP
1,090,000€31.1m-0.91%0.7%
0.91%
Brown Advisory Incorporated
1,085,741€31.0m0.92%0.05%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/12 04:08
End of Day Share Price 2025/05/12 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cytokinetics, Incorporated is covered by 42 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Carter GouldBarclays
Huidong WangBarclays
Jason ZemanskyBofA Global Research